第四代EGFR抑制剂的约束热力学由绝对约束的自由能量计算揭示
Huaxin Zhou1,2, Haohao Fu1,2,3, Xueguang Shao1,2,3
1Research Center for Analytical Sciences, Tianjin Key Laboratory of Biosensing and Molecular Recognition, State Key Laboratory of Medicinal Chemical Biology, College of Chemistry, Nankai University, Tianjin 300071, China.
Journal of chemical information and modeling
|December 6, 2023
概括
像BLU-945这样的第四代EGFRTKI显示强烈的结合于非小细胞肺癌中耐药EGFR突变,提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 表皮生长因子受体 (EGFR) 突变驱动非小细胞肺癌 (NSCLC).
- EGFR氨酸激酶抑制剂 (TKI) 是有效的,但由于突变而面临耐药性.
- 了解耐药机制对于开发下一代疗法至关重要.
研究的目的:
- 调查第四代TKI BLU-945及其类似物与野生型 (EGFRWT),双突变型 (EGFRDM) 和三重突变型 (EGFRTM) 的结合亲缘关系.
- 为了比较BLU-945与erlotinib (第一代TKI) 和另一个第四代TKI,CH7233163.3的结合.
- 阐明涉及TKI与耐药EGFR形式结合的分子相互作用和关键残留物.
主要方法:
- 使用了具有绝对约束力的自由能源计算.
- 计算了BLU-945,类似物,CH7233163和erlotinib的结合亲缘关系.
- 确定了分子相互作用和关键结合残留物.
主要成果:
- 与erlotinib相比,BLU-945和CH7233163对EGFRDM和EGFRTM的结合亲和力更强.
- 关键残留物K745和T854被确定为第四代TKI结合的关键.
- 静电力是第四代TKI与EGFR突变体结合的主要驱动因素.
- 在BLU-945中,piperidinol和硫基显著增强了与EGFR突变体的结合.
结论:
- 第四代EGFRTKI对NSCLC中常见的耐药性突变表现出强烈的结合.
- 这项研究的结构性见解可以指导优化新型EGFR向疗法.
- BLU-945和类似的化合物代表了克服NSCLC中TKI耐药性的有希望的候选者.
相关概念视频
The Equilibrium Binding Constant and Binding Strength
12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
Physiological Pharmacokinetic Models: Assumption with Protein Binding
47
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
47
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Protein-Drug Binding: Determination Methods
210
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
210


